Washington, D.C. Medical Marijuana Sales Top $10.3 Million in June, Reach $57.4 Million in First Half of 2026
- Washington, D.C.’s medical marijuana market generated over $10.3 million in sales in June 2026, marking the second-highest monthly total and contributing to a $57.4 million total for the first half of the year.
- June sales experienced a 23% year-over-year increase, rising from $8.4 million in June 2025 to over $10.3 million in June 2026, according to the District’s Alcoholic Beverage and Cannabis Administration.
- Licensed dispensaries made up $6.57 million of June’s sales, with cultivation centers and manufacturers contributing $853,615 and $2.95 million respectively; flower was the top-selling product category at $3.3 million.
- The number of registered D.C. medical marijuana patients rose to 131,133 in June, with 41,056 unique patients served that month across 69 licensed retailers in the district.
Washington, D.C.’s medical marijuana market generated more than $10.3 million in sales in June, the second-highest monthly total on record, bringing the total for the first half of 2026 to $57.4 million.
The $10,381,484 generated in June represents an increase from $10,021,299 in May and $8,432,503 in June 2025, according to a new report from the District’s Alcoholic Beverage and Cannabis Administration. Year-over-year sales increased by approximately 23%.
When combined with approximately $47 million generated during the first five months of the year, June’s total brings sales for the first half of 2026 to about $57.4 million.
Licensed dispensaries accounted for $6,574,122 of June’s total, down slightly from $6,710,655 in May but up from $5,426,126 during the same month last year.
Cultivation center sales reached $853,615, rising from $727,036 in May and $753,271 in June 2025. Manufacturers generated $2,953,747, compared with $2,583,608 in May and $2,253,106 during the same period last year.
District residents made $4,044,193 in purchases during June, while self-certified temporary patients from outside the district accounted for $2,075,466. Patients participating through reciprocity programs generated an additional $454,463.
Flower remained the largest retail product category, generating $3,325,216 in sales from 736 pounds sold. Vape cartridges generated $1,229,214, followed by infused edibles at $788,283 and raw pre-rolls at $769,748.
The number of registered D.C. resident patients increased from 123,826 in May to 131,133 in June. A total of 41,056 unique patients were served by a registered dispensary during the month, and the district reported 69 licensed retailers.